ロード中...

Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most common and most malignant primary brain cancer in adults. Despite multimodality treatment, the prognosis is still poor. Therefore, further work is urgently required to discover novel therapeutic strategies for GBM treatment. METHODS: The synergistic effects...

詳細記述

保存先:
書誌詳細
出版年:J Exp Clin Cancer Res
主要な著者: Meng, Wei, Wang, Baocheng, Mao, Weiwei, Wang, Jiajia, Zhao, Yang, Li, Qifeng, Zhang, Chenran, Tang, Yujie, Ma, Jie
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167847/
https://ncbi.nlm.nih.gov/pubmed/30285808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0916-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!